Cerebrolysin 60mg

R450,00

Cerebrolysin 60mg

Neurological Improvement, Enhanced Motor Function, Regained Independence, Consciousness, Cognitive Function, Neuroprotection

R450,00

8 in stock

What It Is?

Cerebrolysin is a purified neurotrophic peptide mixture – a complex blend of peptides and amino acids enzymatically derived from porcine brain tissue. Developed in the 1970s in Austria, it contains bioactive fragments that mimic natural brain-derived neurotrophic factors.
It is administered intramuscularly and has been used clinically for over 50 years to support brain repair and recovery. Unlike single synthetic peptides, it is a multimodal ‘brain food’ cocktail.

Think of Cerebrolysin as your brain’s ‘natural repair crew in a bottle’. It doesn’t just protect neurons, it actively helps the brain rebuild and rewire itself.

How it works:

– Mimics endogenous neurotrophic factors and activates key pathways (Shh/Sonic Hedgehog, PI3K/AKT, BDNF, VEGF, IGF-1).
– Promotes neurogenesis (new neurons), synaptogenesis (new connections), angiogenesis (new blood vessels), and reduces inflammation/apoptosis.
– Crosses the blood-brain barrier and supports the neurovascular unit.

– Stroke recovery – faster neurological improvement, better motor function, regained independence, and reduced post-stroke dementia risk.
– Traumatic brain injury (TBI) – improved consciousness, cognitive function, quality of life, and survival rates.
– Dementia & cognitive impairment – enhanced memory, attention, and daily functioning in vascular dementia and Alzheimer’s.
– Bonus signals: neuroprotection in other CNS disorders, reduced inflammation, and potential support for aphasia or psychiatric conditions (emerging data).

In short: It kick-starts the brain’s own self-repair mechanisms, especially powerful when given early after injury or in chronic neurodegeneration.

Cerebrolysin has one of the best safety records among neurotrophic therapies – decades of use with excellent tolerability.
In large trials and post-marketing data: Well-tolerated; adverse events are rare, mild, and transient.
Common/mild:
– Headache, dizziness, nausea, or sweating (usually during infusion).
– Injection/infusion-site reactions (redness, mild pain).
Rare:
– Allergic reactions or flushing (very uncommon)
– Not recommended in epilepsy, severe kidney disease, or hypersensitivity to porcine products.
– No serious systemic toxicity or organ damage reported in approved use.

Bottom line: Exceptionally safe when used as prescribed – side effects are far milder than many neurological drugs.

There Are no guidelines for dosage of cerebrolysin. Many researchers administer 20mg per day and run it for a month. For nootropic benefits, we recommend keeping within these limits. For medical reasons, such as ADHD, depression, Alzheimer’s, we recommend you reach out to your medical practitioner. Cerebrolysin is extremely powerful. It is for advanced researchers, and we recommend considering all options, such as Semax and Selank to start with.

 

For lyophilised powder form, follow the protocol:

This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → 20 mg/mL concentration.
  • Typical daily range: 20mg once daily (gradual titration); split doses for >20 mg
  • Easy measuring: At 20 mg/mL, 100 units on a U‑100 insulin syringe.
  • Storage: Lyophilized at room temperature ≤25 °C (≤77 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days; do not freeze.

 

 

– Porcine brain power – made from purified pig brain proteins (ethically sourced and processed); the peptides mimic human neurotrophic factors almost perfectly.
– Multimodal legend: unlike single-target drugs, it hits multiple repair pathways at once (one of the reasons it is so versatile).
– Stroke recovery pioneer – used in hospitals across Europe/Asia since the 1970s; one of the first -neuro-recovery drugs.
– SHH pathway activator – boosts Sonic Hedgehog signaling (the same pathway that patterns embryos!) for adult brain repair.
– 50+ countries strong – approved and routinely used worldwide except in places like the US and Australia.
– Long-term hero – studies show benefits lasting years after short treatment courses.
Brain’s best friend – nicknamed ‘the brain’s own repair kit’ because it supports everything from new neurons to better blood flow.

Cerebrolysin has robust data from hundreds of trials (especially in Europe/Asia), with thousands of patients. Here are the key ones:

1. Kandasamy et al. (2025) PMC observational study: Cerebrolysin as add-on in acute ischemic stroke significantly improved neurological and functional outcomes.
2. RWACenter clinical summary (2025): Neuroprotection, neurogenesis, and cognitive enhancement; dosing 5-50 ml/day; excellent safety.
3. Florek et al. (2025) Biomedicines review: Supportive role in psychiatry (depression, autism, neuroleptic side effects); cognitive improvements.
4. Staszewski et al. (2022/updated) Frontiers trial: Add-on to mechanical thrombectomy in large-vessel stroke; 30 ml daily for 21 days + repeat course.
5. Official Cerebrolysin site (2026): Multimodal mode of action (NTF + Shh pathways); approved in 50+ countries; not FDA-registered.
6. Cerebrolysin Product Monograph (2021/2026 updates): Clinical efficacy in stroke (early recovery, independence), TBI (survival, cognition), dementia (quality of life); 10–50 ml dosing.
7. Kobayashi et al. (2025) Frontiers pilot (CLINCH trial): Safety and feasibility in primary intracerebral hemorrhage; well-tolerated.
8. Rejdak et al. (2023 Medicinal Research Reviews): Modulation of neurotrophic factors in stroke, TBI, and dementia; excellent safety up to 3 years.
9. Wikipedia & regulatory overviews (2026): Porcine brain-derived; approved indications and mild side effects (nausea, dizziness).
10. EVER Pharma safety data (2026): EMA “SAFE” category; transient mild effects only; decades of clinical application.

Takeaway: Strong real-world and RCT evidence in approved countries for brain recovery; ongoing research expands applications.

Important disclaimer upfront: Cerebrolysin is NOT approved by the FDA (or in the US, SA, Australia, or several other countries) as of 2026 and is not available for sale or distribution there. It IS approved and widely used in over 50 countries (mainly Europe and Asia) as a prescription medication for acute ischemic stroke, traumatic brain injury (TBI), vascular dementia, and Alzheimer’s disease. It requires medical supervision and IV administration in most protocols. Long-term safety is well-established in approved regions. Always talk to a doctor – this is not medical advice.
img_1237

Energy, Focus, Mood Boost, Mental Clarity, Reduced Fatigue, Addiction Recovery, Anti- Aging, Neuroprotection, Reduced Inflammation.

R900,00

Read more
img_1253

Immunity Enhancement, Reduced Inflammation, Improved Energy, Post-Viral Recovery, Wound Recovery Enhancement

R530,00

Add to cart
img_1209

Muscle Growth, Recovery, Fat Loss, Metabolic Booster, Anti-Aging, Wellness, Sleep Enhancement.

R450,00

Read more
img_1242

Neuroprotection, Cognitive Enhancement, Memory, Learning Speed, Focus, Anti-Aging, Brain Support, Neuroinflammation, Strong Sleep Aid.

 

R590,00

Add to cart
img_1208

Enhanced Deep Sleep, Cognitive Benefits, Mood Enhancement, Longevity

R590,00

Add to cart
img_1200

Neuropathic Pain Relief, Anti-inflammatory effects, Tissue protection, Healing, Fatigue, Quality of Life.

R550,00

Add to cart
0